EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3

Cátia F Marques, Maya Narang, Kim A Sharp, Trevor M Penning

Drug Metabolism and Disposition · 2025-09 · 53 (9) · 100142

DOI: 10.1016/j.dmd.2025.100142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-09. Verfasst von Cátia F Marques und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Flunitrazepam, 3-Hydroxysteroid Dehydrogenases, Hydroxyprostaglandin Dehydrogenases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flunitrazepam3-Hydroxysteroid DehydrogenasesHydroxyprostaglandin DehydrogenasesHumansAldo-Keto Reductase Family 1 Member C3Oxidation-ReductionMolecular Docking SimulationActivation, Metabolic20-Hydroxysteroid Dehydrogenases3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)

Stichwörter der Autor:innen

Aldo-keto reductasesDrug metabolismHepatoma cellsMass spectrometry

Substanzen

Aldo-Keto Reductase Family 1 Member C3FlunitrazepamAKR1C3 protein, human3-Hydroxysteroid DehydrogenasesHydroxyprostaglandin Dehydrogenases20-Hydroxysteroid DehydrogenasesAKR1C2 protein, human3 alpha-beta, 20 beta-hydroxysteroid dehydrogenase3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)

Autor:innen und Institutionen

  • Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center of Excellence in Environmental Toxicology, Perelman School of…

Förderung

  • NIEHS NIH HHS
  • NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institutes of Health
  • National Institutes of Health Office of Research Infrastructure Programs
  • American Cancer Society

Zitieren

APA

Marques, C. F., Narang, M., Sharp, K. A., & Penning, T. M. (2025). Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3. Drug Metabolism and Disposition, 53(9), 100142. https://doi.org/10.1016/j.dmd.2025.100142

Vancouver

Marques CF, Narang M, Sharp KA, Penning TM. Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3. Drug Metabolism and Disposition. 2025;53(9):100142. doi:10.1016/j.dmd.2025.100142

BibTeX
@article{Marques2025,
  author = {Marques, Cátia F and Narang, Maya and Sharp, Kim A and Penning, Trevor M},
  title = {Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  volume = {53},
  number = {9},
  pages = {100142},
  doi = {10.1016/j.dmd.2025.100142}
}
Kostenlos starten →